Next Article in Journal
Potent NTD-Targeting Neutralizing Antibodies against SARS-CoV-2 Selected from a Synthetic Immune System
Next Article in Special Issue
A Serological Analysis of the Humoral Immune Responses of Anti-RBD IgG, Anti-S1 IgG, and Anti-S2 IgG Levels Correlated to Anti-N IgG Positivity and Negativity in Sicilian Healthcare Workers (HCWs) with Third Doses of the mRNA-Based SARS-CoV-2 Vaccine: A Retrospective Cohort Study
Previous Article in Journal
Immunotherapy of Equine Sarcoids—From Early Approaches to Innovative Vaccines
Previous Article in Special Issue
The Four Ws of the Fourth Dose COVID-19 Vaccines: Why, Who, When and What
 
 
Article

Article Versions Notes

Vaccines 2023, 11(4), 770; https://doi.org/10.3390/vaccines11040770
Action Date Notes Link
article xml file uploaded 30 March 2023 14:28 CEST Original file -
article xml uploaded. 30 March 2023 14:28 CEST Update https://www.mdpi.com/2076-393X/11/4/770/xml
article pdf uploaded. 30 March 2023 14:28 CEST Version of Record https://www.mdpi.com/2076-393X/11/4/770/pdf
article html file updated 30 March 2023 14:29 CEST Original file -
article html file updated 6 April 2023 23:54 CEST Update https://www.mdpi.com/2076-393X/11/4/770/html
Back to TopTop